Chinese english Germany Japanese Korea

N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide

N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide Struktur
1081134-48-6
CAS-Nr.
1081134-48-6
Englisch Name:
N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide
Synonyma:
N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide;2H-1-Benzopyran-6-propanamide, N-(2-chloro-4-pyridinyl)-4-methyl-7-[(2-methyl-2-propen-1-yl)oxy]-2-oxo-
CBNumber:
CB84026387
Summenformel:
C22H21ClN2O4
Molgewicht:
412.87
MOL-Datei:
1081134-48-6.mol
Request For Quotation

N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide Eigenschaften

Siedepunkt:
665.5±55.0 °C(Predicted)
Dichte
1.294±0.06 g/cm3(Predicted)
pka
12.78±0.70(Predicted)

Sicherheit

N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide Chemische Eigenschaften,Einsatz,Produktion Methoden

N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
VITAS-M LABORATORY, LTD. --
 Russia 6754 64
OTAVA chemicals --
 north.america@otavachemicals.com Ukraine 6495 72
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
  • N-(2-chloropyridin-4-yl)-3-{4-methyl-7-[(2-methylprop-2-en-1-yl)oxy]-2-oxo-2H-chromen-6-yl}propanamide
  • 2H-1-Benzopyran-6-propanamide, N-(2-chloro-4-pyridinyl)-4-methyl-7-[(2-methyl-2-propen-1-yl)oxy]-2-oxo-
  • 1081134-48-6
Copyright 2019 © ChemicalBook. All rights reserved